Insiders who reported open-market trades in the last 12 months at the companies Jeff Cislini files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
Margaret A. Horn - $25.81M in RVMD purchases and sales in the last 12 months
Jeff Cislini is a corporate insider, tracked as SVP & General Counsel of Revolution Medicines, Inc. (RVMD). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeff Cislini submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jeff Cislini been buying or selling stock?
Recorded transactions: 0 open-market purchases and 22 open-market sales ($16.31M) across all tracked filings.
Jeff Cislini is SVP & General Counsel of Revolution Medicines, Inc. (RVMD). 16 SEC Form 4 filings on record going back to 2024, most recently on 29 September 2026. Most recent open-market trade: sold $159K of RVMD on 29 September 2026. Lifetime open-market sales: $16.31M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Jeff Cislini.
InsiderAlpha's records for Jeff Cislini go back to 2024: 16 primary Form 4 filings, an average of 5.3 per year. 32 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
